Is Arbutus Biopharma Corp (ABUS) a Buy, Sell, or Hold?
Arbutus Biopharma Corp
NASDAQ:ABUS
$4.545 USD
-$0.07 (-1.41%)
- Volume
- 288.57K
- Average Volume
- 2.15M
- Market Capitalization
- $897.81M
- P/E Ratio
- 5.45
- Dividend Yield
- 0.00%
- Price Target
- $8.50
- Year High
- $5.38
- Year Low
- $3.08
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $54.26
ABUS vs. The Competition
| Properties | ABUS | BCAX | EYPT | GHRS |
|---|---|---|---|---|
| Market Cap | $897.81M | $1.53B | $1.16B | $1.82B |
| Shares Outstanding | $197.54M | $54.78M | $83.84M | $68.56M |
| P/E Ratio | 5.45 | -10.04 | -3.94 | -28.84 |
| EPS | 0.83 | -2.59 | -3.16 | -0.91 |
| Day Low | 4.495 | 27.7 | 13.485 | 26.2459 |
| Day high | 4.59 | 28.285 | 13.915 | 26.72 |
| Year Low | 3.08 | 9.57 | 9.4 | 11.32 |
| Year High | 5.38 | 30.99 | 19.11 | 28.96 |
| Average Price 50 | 4.4884 | 23.5292 | 13.2728 | 23.2574 |
| Average Price 200 | 4.4434 | 19.20058 | 14.1562 | 16.99117 |
| Volume | 288.57K | 56650.81 | 173.68K | 11367.92 |
| Average Volume | - | - | - | - |